Magnetic hyperthermia (MHT) is a therapeutic modality for the treatment of solid tumors that
has now accumulated more than 30 years of experience. In the ongoing MHT clinical trials …

Significant research and preclinical investment in cancer nanomedicine has produced
several products, which have improved cancer care. Nevertheless, there exists a perception …

Nanomaterials, in addition to their small size, possess unique physicochemical properties
that differ from bulk materials, making them ideal for a host of novel applications. Magnetic …

Magnetic nanoparticles (NPs) are emerging as an important class of biomedical functional
nanomaterials in areas such as hyperthermia, drug release, tissue engineering, theranostic …

Nowadays, magnetic hyperthermia constitutes a complementary approach to cancer
treatment. The use of magnetic particles as heating mediators, proposed in the 1950s …

Magnetic iron oxide nanoparticles (IONPs) are heavily explored as diagnostic and
therapeutic agents due to their low cost, tunable properties, and biocompatibility. In …

Localized magnetic hyperthermia using magnetic nanoparticles (MNPs) under the
application of small magnetic fields is a promising tool for treating small or deep-seated …

Drug delivery strategies aim to maximize a drug's therapeutic index by increasing the
concentration of drug at target sites while minimizing delivery to off‐target tissues. Because …

Under the right process conditions, nanoparticles can cluster together to form defined,
dispersed structures, which can be termed supraparticles. Controlling the size, shape, and …

Nanostructured magnetic systems have many applications, including potential use in cancer
therapy deriving from their ability to heat in alternating magnetic fields. In this work we …